Prof G's MS-Selfie Newsletter
Who should control access to AHSCT as a treatment for MS? The patient, the healthcare provider or the healthcare system? Have your say!
Comment 49Share
NewTopCommunityWhat is Prof G's MS-Selfie Newsletter?About
A Saturday morning doodle what do you think?I am trying to create a logo for the MS-Selfie Newsletter. This is my first attempt what do you think? Does the self-help philosophy behind what…
Comment 59Share
A case of rapidly progressing secondary progressive MS despite treatment with rituximab. How to investigate and manage SPMS and at the same time managi…
Comment 4Share
Having some idea of how bad your MS is, or not, will allow you to discuss with your neurologist issues around what level of treatment is appropriate fo…
Comment 15Share
A patient with rapidly-evolving severe MS is having doubts about the decision to be treated with cladribine. Should she abort the cladribine and have A…
Comment 8Share
Why is death and dying such a taboo for MS stakeholders and society in general? Have you completed an advanced directive or living will?
Comment 20Share
A colleague suggested to me that the whole academic neurology community has imbibed too much anti-CD20 Kool-Aid and it is time for us to sober up. Is s…
Comment 35Share
This patient wants to switch from an anti-CD20 therapy to oral cladribine in the hope that it is going to allow him to make an antibody response to the…
Comment 5Share
See all

Prof G's MS-Selfie Newsletter


What is Prof G's MS-Selfie Newsletter?ArchiveAuthorsMy Account
© 2021 Gavin Giovannoni. See privacy, terms and information collection notice
Publish on Substack
Prof G's MS-Selfie Newsletter is on Substack – the place for independent writing